Rubella virus chronic inflammatory disease and other unusual viral phenotypes in inborn errors of immunity

Gonench Kilich1, Ludmila Perelygina2, Kathleen E Sullivan1

  • 1Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA.

Immunological Reviews
|November 27, 2023
PubMed

Insights

Patients with inborn errors of immunity (IEI) may present with unusual viral infections, not just bacterial ones. Recognizing these rare viral phenotypes and their skin manifestations is crucial for timely treatment and improved outcomes.

Area of Science:

  • Immunology
  • Virology
  • Oncology

Background:

  • Infectious susceptibility is a hallmark of inborn errors of immunity (IEI).
  • Reliance on antibiotic history for susceptibility assessment overlooks viral phenotypes.
  • Unusual viral manifestations in immune compromise can be misdiagnosed.

Purpose of the Study:

  • To review unusual viral infection phenotypes in patients with IEI and immune compromise.
  • To highlight viral-induced oncogenesis and tumor-like growths.
  • To increase awareness and guide treatment for these rare viral presentations.

Main Methods:

  • Literature review of viral infections in immunocompromised individuals.
  • Focus on enterovirus, rubella, measles, papillomavirus, and parvovirus B19.
  • Description of viral-induced oncogenesis mechanisms.

Main Results:

  • Several viruses (enterovirus, rubella, measles, papillomavirus, parvovirus B19) present with unusual phenotypes in IEI.
  • Chronic infections can lead to oncogenesis and tumor-like growths.
  • Cutaneous manifestations are common across these viral infections.

Conclusions:

  • Early recognition of unusual viral phenotypes in IEI is critical.
  • Understanding viral-induced oncogenesis aids in managing complex cases.
  • Awareness of cutaneous signs can aid diagnosis and improve patient outcomes.

Related Concept Videos

Immunodeficiency Diseases01:25

Immunodeficiency Diseases

Immunodeficiency disorders are conditions in which the immune system's ability to fight infectious disease and cancer is compromised or entirely absent. The immune system comprises a complex network of cells, tissues, and organs that work together to protect the body from potentially harmful invaders. When this system is deficient or not functioning properly, it leaves the body susceptible to infections, diseases, or other complications.
There are three main causes of immunodeficiency...
947
Viral Recombination00:57

Viral Recombination

Cells are sometimes infected by more than one virus at once. When two viruses disassemble to expose their genomes for replication in the same cell, similar regions of their genomes can pair together and exchange sequences in a process called recombination. Alternatively, viruses with segmented genomes can swap segments in a process called reassortment.
23.5K
Rh Blood Group01:19

Rh Blood Group

The Rhesus (Rh) antigen is crucial in determining blood groups and ensuring compatibility during blood transfusions.
1.5K
Rous Sarcoma Virus (RSV) and Cancer01:03

Rous Sarcoma Virus (RSV) and Cancer

Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand  RNA genome. Its genome consists of four main open...
5.1K
Mechanisms of Retrovirus-induced Cancers01:51

Mechanisms of Retrovirus-induced Cancers

Retroviruses are RNA viruses that have been shown to cause cancers in diverse species, including chickens, mice, cats, and monkeys. The RNA genomes of these viruses are first reverse-transcribed into single and then double-stranded DNA (dsDNA) copies. This dsDNA called proviral DNA then integrates into the host genome. Subsequently, the host cell transcribes the proviral DNA in concert with the chromosomal DNA. This leads to the production of viral RNA and proteins that assemble at the host...
5.1K
Development of Immunocompetence01:22

Development of Immunocompetence

The initiation of cell-mediated immunity can be observed as early as the third month of fetal growth, with active antibody-mediated immunity following approximately one month later.
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
315